Merit Medical Systems (MMSI) Stock Price

Merit Medical Systems Price

NASDAQ·CLOSED
85.01USD+1.66 (+1.97 %)
Market closed

Revenue has compounded at 11.5% per year over the past 19 years to 1.51 B USD. Earnings per share have grown at 10.0% per year over the last 19 years. Merit Medical Systems's net margin stands at 8.5%, up from 4.5% several years earlier. Analysts set a median price target of 108.12 USD, implying 27.2% above the current price. Of 17 analysts, 15 rate the stock a buy — an overall Buy consensus. The stock trades about 41% above its 52-week low.

Merit Medical Systems stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Merit Medical Systems over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Merit Medical Systems stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Merit Medical Systems's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Merit Medical Systems Stock Price History
DateMerit Medical Systems Price
7/31/202685.01 USD
7/30/202683.35 USD
7/29/202679.42 USD
7/27/202675.98 USD
7/23/202673.11 USD
7/22/202673.11 USD
7/21/202673.48 USD
7/20/202675.17 USD
7/17/202673.99 USD
7/16/202675.55 USD
7/15/202673.04 USD
7/14/202671.02 USD
7/13/202673.66 USD
7/10/202673.44 USD
7/9/202671.46 USD
7/8/202671.25 USD
7/7/202672.14 USD
7/6/202671.14 USD
7/2/202671.09 USD
7/1/202669.45 USD
6/30/202669.34 USD
6/29/202670.71 USD
6/26/202671.73 USD
6/25/202670.83 USD
6/24/202669.20 USD
6/23/202667.27 USD
6/22/202666.67 USD
6/18/202667.07 USD
6/17/202667.40 USD
6/16/202667.79 USD
6/15/202666.87 USD
6/12/202666.82 USD
6/11/202666.48 USD
6/10/202667.15 USD
6/9/202667.51 USD
6/8/202666.03 USD
6/5/202664.06 USD
6/4/202663.99 USD
6/3/202660.52 USD
6/2/202660.58 USD
6/1/202661.91 USD
5/29/202664.19 USD
5/28/202663.08 USD
5/27/202663.75 USD
5/26/202664.05 USD
5/22/202663.70 USD
5/21/202663.88 USD
5/20/202663.90 USD
5/19/202663.77 USD
5/18/202663.64 USD
5/15/202661.36 USD
5/14/202662.56 USD
5/13/202662.62 USD
5/12/202661.15 USD
5/11/202660.31 USD
5/8/202661.27 USD
5/7/202662.33 USD
5/6/202661.63 USD
5/5/202660.44 USD
5/4/202662.01 USD
5/1/202662.01 USD
4/30/202668.18 USD
4/29/202664.84 USD
4/28/202666.74 USD
4/27/202667.43 USD
4/24/202668.58 USD
4/23/202668.61 USD
4/22/202669.72 USD
4/21/202667.87 USD
4/20/202669.79 USD
4/17/202670.93 USD
4/16/202670.10 USD
4/15/202670.73 USD
4/14/202670.54 USD
4/13/202670.57 USD
4/10/202668.26 USD
4/9/202668.65 USD
4/8/202669.24 USD
4/7/202667.40 USD
4/6/202667.81 USD
4/2/202667.70 USD
4/1/202668.23 USD
3/31/202668.93 USD
3/30/202668.64 USD
3/27/202668.73 USD
3/26/202669.31 USD
3/25/202668.11 USD
3/24/202667.55 USD
3/23/202668.13 USD
3/20/202666.71 USD
3/19/202668.33 USD
3/18/202668.33 USD
3/17/202670.23 USD
3/16/202669.17 USD
3/13/202669.95 USD
3/12/202668.17 USD
3/11/202670.08 USD
3/10/202669.71 USD
3/9/202671.88 USD
3/6/202672.66 USD
3/5/202673.49 USD
3/4/202674.16 USD
3/3/202674.85 USD
3/2/202676.50 USD
2/27/202677.18 USD
2/26/202678.02 USD
2/25/202679.23 USD
2/24/202682.43 USD
2/23/202681.61 USD
2/20/202682.21 USD
2/19/202681.84 USD
2/18/202682.98 USD
2/17/202681.59 USD
2/13/202681.27 USD
2/12/202678.86 USD
2/11/202681.29 USD
2/10/202682.22 USD
2/9/202680.83 USD
2/6/202682.50 USD
2/5/202679.63 USD
2/4/202679.37 USD
2/3/202680.49 USD
2/2/202681.61 USD
1/30/202681.09 USD
1/29/202680.24 USD
1/28/202680.50 USD
1/27/202682.40 USD
1/26/202682.54 USD
1/23/202681.68 USD
1/22/202683.39 USD
1/21/202683.45 USD
1/20/202681.70 USD
1/16/202682.31 USD
1/15/202680.35 USD
1/14/202681.75 USD
1/13/202681.08 USD
1/12/202683.25 USD
1/9/202687.02 USD
1/8/202693.18 USD
1/7/202691.65 USD
1/6/202693.04 USD
1/5/202689.42 USD
1/2/202686.45 USD
12/31/202588.14 USD
12/30/202588.56 USD
12/29/202588.22 USD
12/26/202587.39 USD
12/24/202587.39 USD
12/23/202587.63 USD
12/22/202587.92 USD
12/19/202587.70 USD
12/18/202587.47 USD
12/17/202587.23 USD
12/16/202586.85 USD
12/15/202586.41 USD
12/12/202586.70 USD
12/11/202586.53 USD
12/10/202585.42 USD
12/9/202583.39 USD
12/8/202583.11 USD
12/5/202583.43 USD
12/4/202584.09 USD
12/3/202584.29 USD
12/2/202584.39 USD
12/1/202586.39 USD
11/28/202586.59 USD
11/26/202587.41 USD
11/25/202587.60 USD
11/24/202587.17 USD
11/21/202587.20 USD
11/20/202584.88 USD
11/19/202583.69 USD
11/18/202584.17 USD
11/17/202585.79 USD
11/14/202585.09 USD
11/13/202587.40 USD
11/12/202588.12 USD
11/11/202589.39 USD
11/10/202588.33 USD
11/7/202587.55 USD
11/6/202586.51 USD
11/5/202587.11 USD
11/4/202588.47 USD
11/3/202587.34 USD
10/31/202587.54 USD
10/30/202587.52 USD
10/29/202581.41 USD
10/28/202582.79 USD
10/27/202582.75 USD
10/24/202582.75 USD
10/23/202583.33 USD
10/22/202584.52 USD
10/21/202584.15 USD
10/20/202583.21 USD
10/17/202581.86 USD
10/16/202580.81 USD
10/15/202580.47 USD
10/14/202580.56 USD
10/13/202579.43 USD
10/10/202578.64 USD
10/9/202582.48 USD
10/8/202583.74 USD
10/7/202582.70 USD
10/6/202583.31 USD
10/3/202584.40 USD
10/2/202582.46 USD
10/1/202582.08 USD
9/30/202583.23 USD
9/29/202580.86 USD
9/28/202580.86 USD
9/25/202580.20 USD
9/24/202580.06 USD
9/23/202583.72 USD
9/22/202583.59 USD
9/19/202583.58 USD
9/18/202584.10 USD
9/17/202582.70 USD
9/16/202582.69 USD
9/15/202582.93 USD
9/12/202585.92 USD
9/11/202590.21 USD
9/10/202588.79 USD
9/9/202591.66 USD
9/8/202592.33 USD
9/5/202592.69 USD
9/4/202592.15 USD
9/3/202590.09 USD
9/2/202590.68 USD
8/29/202590.56 USD
8/28/202590.05 USD
8/27/202590.79 USD
8/26/202589.06 USD
8/25/202588.16 USD
8/22/202589.38 USD
8/21/202586.63 USD
8/20/202587.36 USD
8/19/202587.15 USD
8/18/202586.16 USD
8/15/202585.53 USD
8/14/202585.22 USD
8/13/202586.15 USD
8/12/202584.76 USD
8/11/202584.04 USD
8/8/202585.70 USD
8/7/202585.65 USD
8/6/202585.24 USD
8/5/202584.49 USD
8/4/202585.38 USD
Access this data via the Eulerpool API
Get Free API Key

Merit Medical Systems Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.26 B USD
123.94 M USD
94.41 M USD
Jan 1, 2024
1.36 B USD
155.69 M USD
120.36 M USD
Jan 1, 2025
1.51 B USD
184.38 M USD
128.49 M USD
Jan 1, 2026 (e)
1.62 B USD
156.00 M USD
246.25 M USD
Jan 1, 2027 (e)
1.72 B USD
165.41 M USD
266.02 M USD
Jan 1, 2028 (e)
1.82 B USD
174.92 M USD
287.46 M USD
Jan 1, 2029 (e)
1.93 B USD
185.56 M USD
303.88 M USD
Jan 1, 2030 (e)
2.04 B USD
196.82 M USD
325.27 M USD

Merit Medical Systems Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 11:36 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.540.600.730.880.990.961.071.151.261.361.511.621.721.821.932.04
6.4811.2520.5621.3212.70-3.1211.537.089.307.8811.656.946.055.776.066.07
43.3643.9544.8444.6743.4641.6445.1645.1346.3847.4248.6148.6148.6148.6148.6148.61
235.00265.00326.00394.00432.00401.00485.00519.00583.00643.00736.00787.04834.68882.81936.29993.16
37.0034.0040.0058.0014.00-1.0060.0087.00123.00155.00184.00155.00165.00174.00185.00196.00
6.835.645.506.581.41-0.105.597.579.7911.4312.159.579.619.589.619.59
23.0020.0027.0042.005.00-9.0048.0074.0094.00120.00128.00246.00266.00287.00303.00325.00
4.55-13.0435.0055.56-88.10-280.00-633.3354.1727.0327.666.6792.198.137.895.577.26
44.6445.1751.7256.5155.2156.7457.6257.9658.3960.6160.0360.0360.0360.0360.0360.03
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Merit Medical Systems generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Merit Medical Systems retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Merit Medical Systems's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Merit Medical Systems has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Merit Medical Systems's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Merit Medical Systems stock margins

The Merit Medical Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Merit Medical Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Merit Medical Systems.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
45.16 %
5.67 %
4.51 %
Jan 1, 2022
45.10 %
7.61 %
6.47 %
Jan 1, 2023
46.44 %
9.86 %
7.51 %
Jan 1, 2024
47.43 %
11.48 %
8.87 %
Jan 1, 2025
48.65 %
12.17 %
8.48 %
Jan 1, 2026 (e)
48.65 %
9.63 %
15.20 %
Jan 1, 2027 (e)
48.65 %
9.63 %
15.49 %
Jan 1, 2028 (e)
48.65 %
9.63 %
15.83 %

Merit Medical Systems Stock Revenue, EBIT, Earnings per Share

The Merit Medical Systems earnings per share therefore indicates how much revenue Merit Medical Systems has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
18.65 USD
1.06 USD
0.84 USD
Jan 1, 2022
19.86 USD
1.51 USD
1.29 USD
Jan 1, 2023
21.54 USD
2.12 USD
1.62 USD
Jan 1, 2024
22.38 USD
2.57 USD
1.99 USD
Jan 1, 2025
25.23 USD
3.07 USD
2.14 USD
Jan 1, 2026 (e)
26.79 USD
2.60 USD
4.07 USD
Jan 1, 2027 (e)
28.41 USD
2.76 USD
4.40 USD
Jan 1, 2028 (e)
30.04 USD
2.91 USD
4.75 USD

Merit Medical Systems business model & stock analysis

Merit Medical Systems Inc. is a globally active medical technology company specializing in the development and production of innovative, high-quality medical devices. The company's headquarters is located in South Jordan, Utah, USA. Over the years, Merit Medical has become a major provider of medical devices and accessories for hospitals, health centers, medical practices, and clinics worldwide. The company was founded in 1987 and has been listed on the NASDAQ stock exchange since 1996.

Merit Medical Systems Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Merit Medical Systems Employees
Details
Date
Merit Medical Systems Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Merit Medical Systems Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Merit Medical Systems historical P/E ratio, EBIT multiple, and P/S ratio

Merit Medical Systems annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Merit Medical Systems shares outstanding

The number of shares of Merit Medical Systems was 60.03 M in 2025. This indicates how many shares Merit Medical Systems is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
57.62 M Stocks
Jan 1, 2022
57.96 M Stocks
Jan 1, 2023
58.39 M Stocks
Jan 1, 2024
60.61 M Stocks
Jan 1, 2025
60.03 M Stocks
Jan 1, 2026 (e)
60.03 M Stocks
Jan 1, 2027 (e)
60.03 M Stocks
Jan 1, 2028 (e)
60.03 M Stocks

Merit Medical Systems stock splits

In Merit Medical Systems's history, there have been no stock splits.

Current Merit Medical Systems forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
88.24 % (15)
Hold
11.76 % (2)
Sell
0.00 % (0)
12M Price Target
108.12
Last Price
85.01
Currency
USD
12M Return Potential
27.19 %
LTM Return
0 %

Merit Medical Systems Analyst Rating Actions

DateFirmActionRatingReliability
7/31/2026
Wells Fargo
Wells Fargo
MaintainedEqual Weight56
7/31/2026
Piper Sandler
Piper Sandler
MaintainedOverweight51
7/31/2026
Needham
Needham
MaintainedBuy70
7/31/2026
JP Morgan
JP Morgan
MaintainedOverweight80
7/31/2026
BTIG
BTIG
MaintainedBuy–
5/1/2026
Wells Fargo
Wells Fargo
MaintainedEqual Weight56
5/1/2026
Needham
Needham
MaintainedBuy70
5/1/2026
JP Morgan
JP Morgan
MaintainedOverweight80
5/1/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
4/20/2026
Barrington Research
Barrington Research
MaintainedOutperform–

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Merit Medical Systems Earnings Calls

2025

Merit Medical Systems Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
7/30/20260.98USD-413.37 MUSD-2026 Q2
4/30/20260.85USD-385.39 MUSD-2026 Q1
2/24/20260.97USD-397.67 MUSD-2025 Q4
4/24/20240.70USD-324.07 MUSD-2024 Q1
2/20/20240.77USD-321.04 MUSD-2023 Q4
7/25/20230.79USD-311.32 MUSD-2023 Q2
4/25/20230.59USD-289.19 MUSD-2023 Q1
2/22/20230.68USD-294.51 MUSD-2022 Q4
10/26/20220.54USD-276.10 MUSD-2022 Q3
7/27/20220.59USD-285.23 MUSD-2022 Q2
...

EESG©

Eulerpool ESG Scorecard© for the Merit Medical Systems stock

77/100
73
Environment
95
Social
62
Governance
E

Environment

20
Scope 1 - Direct Emissions2,875
Scope 2 - Indirect emissions from purchased energy15,476
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions18,359
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees57
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Merit Medical Systems shareholder structure

% Name
14.61183%
BLACKROCK, INC.
BLACKROCK, INC.
13.15319%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
10.86324%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
5.82714%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.39326%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
3.90503%
STATE STREET CORP
STATE STREET CORP
...

Merit Medical Systems Beneficial Ownership Filings (SEC 13D/G)

Free Float
97.6%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
14.10%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
12.30%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
11.00%
St. James’s Place Global Equity Unit Trust
St. James’s Place Global Equity Unit Trust
SEC ↗
11.00%
EdgePoint Investment Group Inc.
EdgePoint Investment Group Inc.
SEC ↗
11.00%
EdgePoint Global Portfolio
EdgePoint Global Portfolio
SEC ↗
11.00%
EdgePoint Global Growth & Income Portfolio
EdgePoint Global Growth & Income Portfolio
SEC ↗
11.00%
Cymbria Corporation
Cymbria Corporation
SEC ↗
11.00%
EdgePoint Canadian Portfolio
EdgePoint Canadian Portfolio
SEC ↗
11.00%
EdgePoint Canadian Growth & Income Portfolio
EdgePoint Canadian Growth & Income Portfolio
SEC ↗
10.30%
EdgePoint Investment Group Inc. (the successor corporation to EdgePoint Investment Management Inc.
EdgePoint Investment Group Inc. (the successor corporation to EdgePoint Investment Management Inc.
SEC ↗

Merit Medical Systems Executives and Management Board

15 members · avg. age 62 · 33 % women

RP

Mr. Raul Parra (47)

Chief Financial Officer, Treasurer

3.17 M USD

Management

NP

Mr. Neil Peterson (59)

Chief Operating Officer

3.14 M USD
BL

Mr. Brian Lloyd (64)

Chief Legal Officer, Corporate Secretary

3.10 M USD
MA

Ms. Martha Aronson (57)

President, Chief Executive Officer, Director · since 2025

–
MV

Mr. Michel Voigt (52)

Chief Human Resources Officer

–
MP

Mr. Mike Piccinino

IR Contact Officer · since 2021

–

Board of Directors

FM

Dr. F. Ann Millner (73)

Independent Chairman of the Board

330,974.00 USD
LW

Ms. Lynne Ward (66)

Independent Director

305,974.00 USD
LC

Mr. Lonny Carpenter (63)

Independent Director

300,974.00 USD
TG

Mr. Thomas Gunderson (74)

Independent Director

300,974.00 USD
DF

Mr. David Floyd (64)

Independent Director

295,349.00 USD
RE

Rear Adm. (Retd.) Stephen Evans (60)

Independent Director

285,974.00 USD

Frequently asked questions about Merit Medical Systems

Merit Medical Systems Inc is a medical device company that focuses on designing, manufacturing, and distributing medical products to improve patient outcomes. Their business model involves developing and providing innovative and high-quality medical devices and accessories to healthcare professionals worldwide. Merit Medical systems Inc aims to enhance patient care and clinical outcomes through their comprehensive portfolio of products, which includes catheters, inflation devices, guide wires, and many other medical devices. Their commitment to research, development, and continuous innovation has made them a trusted name in the medical industry.

Merit Medical Systems Inc is primarily active in the healthcare industry.

The main competitors of Merit Medical Systems Inc in the market include Becton Dickinson and Company, Boston Scientific Corporation, Medtronic PLC, and Smiths Medical.

Merit Medical Systems Inc is a reputable company in the medical device industry. Established in 1987, Merit Medical specializes in developing and manufacturing innovative and high-quality medical devices to enhance patient outcomes worldwide. With a focus on interventional and diagnostic procedures, the company offers a broad range of products including catheters, syringes, drainage systems, and more. Merit Medical has grown significantly since its inception, expanding its global presence through strategic acquisitions and partnerships. Its commitment to delivering superior healthcare solutions has earned Merit Medical a strong reputation among healthcare professionals and patients alike.

Merit Medical Systems Inc has achieved several significant milestones throughout its history. Since its inception, the company has strived to provide innovative and high-quality medical products to healthcare professionals and patients globally. One notable milestone is the development and commercialization of the unique Merit Laureate® hydrophilic guide wire, which offers enhanced trackability and navigation during medical procedures. Additionally, Merit Medical Systems Inc has successfully expanded its product portfolio, introducing a wide range of state-of-the-art devices for cardiovascular, endoscopy, and interventional radiology procedures. The company's commitment to research and development, coupled with its dedication to improving patient outcomes, has solidified Merit Medical Systems Inc as a trusted leader in the medical device industry.

Merit Medical Systems Inc is primarily present in various countries and regions across the globe. As a leading healthcare company, Merit Medical Systems Inc operates in North America, Europe, Asia-Pacific, Latin America, and the Middle East. With a widespread presence, the company serves healthcare professionals and patients alike in these regions. Merit Medical Systems Inc's commitment to expanding its presence across diverse markets underscores its dedication to providing innovative medical devices and solutions internationally.

Merit Medical Systems Inc represents values and a corporate philosophy centered around patient care, innovation, integrity, and collaboration. As a leading global manufacturer and distributor of medical devices and supplies, Merit Medical Systems Inc prioritizes improving patient outcomes through the development of cutting-edge medical solutions. With a commitment to ethical business practices, the company strives to maintain the trust of healthcare professionals and patients alike. Merit Medical Systems Inc fosters a culture of innovation, leveraging expertise and partnerships to deliver advanced medical technologies. By placing emphasis on collaboration and teamwork, the company strives to continuously improve patient care and positively impact the healthcare industry.

Analysts currently set an average price target of 106.08 USD for the Merit Medical Systems stock (median: 108.12 USD), implying +24.8 % versus the latest price. The consensus is based on 17 analyst ratings.

Merit Medical Systems Analyst Price Targets 2026

18 analysts currently rate the Merit Medical Systems stock: 15 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Merit Medical Systems to generate revenue of 1.62 B USD and earnings per share of 4.10 USD.

Merit Medical Systems Analyst Price Targets 2026

Converted at the current exchange rate, the Merit Medical Systems share trades at 73.85 EUR (85.01 USD).

The Merit Medical Systems share (MMSI) is listed on 3 stock exchanges, including: NASDAQ (MMSI), Frankfurt (MM3.F), München (MM3.MU).

Merit Medical Systems Inc. is a US-based company that specializes in the development, manufacturing, and distribution of products for the diagnosis, treatment, and management of patients with critical medical needs. The company was founded in 1987 and works closely with physicians and healthcare professionals to develop innovative products that enable improved clinical efficiency and patient outcomes. Merit Medical Systems focuses on various areas such as interventional radiology, cardiology, endoscopy, dialysis, oncology, and infusion. Each area has its own unique range of products tailored to the specific needs of patients and healthcare professionals. In the field of interventional radiology, Merit Medical Systems offers a wide range of products such as catheters, guide wires, and stents for diagnostic and therapeutic purposes. This includes products like Embosphere Microspheres embolization particles for the treatment of liver tumors and the AceWire guide wire system. In cardiology, Merit Medical focuses on providing solutions for complex cardiac procedures including the treatment of congenital heart defects, vascular narrowing, or valve problems. One example is the Prelude Sheath Introducer system for transcatheter aortic valve implantation (TAVI), a minimally invasive alternative to open heart surgery. In the field of endoscopy, Merit Medical Systems offers a wide range of products for diagnostic and therapeutic purposes for the gastrointestinal tract system, such as the Bull's Horn Suprapubic Catheter for percutaneous kidney stone removal. In the field of dialysis, Merit Medical Systems' portfolio includes products for hemodialysis, peritoneal dialysis, and hemofiltration. One example is the Hero Graft for dialysis patients, which allows for long-lasting and secure vascular access maintenance. In oncology, Merit Medical focuses on interventions for tumors, such as the STAR Tumor Ablation System for the treatment of malignant liver tumors, the eIFU NanoKnife for the treatment of soft tissue tumors like the pancreas or lung. Another important segment of Merit Medical Systems is infusion, which includes a wide range of products such as catheters, ports, and infusion pumps for medication and fluid delivery. The Spectrum Catheter and Port system are notable in this area. Merit Medical Systems has an extensive network of sales partners and branches throughout North America, Europe, the Middle East, and Asia to deliver products to customers quickly and effectively. The company's business model is based on providing innovative, high-quality products along with excellent customer service and training to create value for customers. Merit Medical Systems follows a strategy of continuously increasing market share to enhance revenue growth and profitability. In summary, Merit Medical Systems is an innovative company specializing in the development, manufacturing, and distribution of products for critical medical applications. With a wide range of areas and products, the company focuses on continuous innovation, high quality, and excellent customer service to increase its market share and competitiveness.

The expected revenue of Merit Medical Systems is 1.62 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Merit Medical Systems is 246.25 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Merit Medical Systems is currently 20.72. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Merit Medical Systems stock.

The price-to-sales ratio (P/S) of Merit Medical Systems is currently 3.15. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Merit Medical Systems stock.

The Eulerpool Quality Score for Merit Medical Systems is 5/10.

The ISIN of Merit Medical Systems is US5898891040. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Merit Medical Systems is 882361. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Merit Medical Systems is MMSI. The ticker symbol is used to trade Merit Medical Systems shares on the stock exchange.

Merit Medical Systems paid dividends every year for the past 0 years.

Merit Medical Systems is assigned to the 'Health' sector.

The dividends of Merit Medical Systems are distributed in USD.

All fundamentals and in-depth analysis of Merit Medical Systems

Our stock analysis for Merit Medical Systems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merit Medical Systems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Merit Medical Systems Stock
Merit Medical Systems Revenue→
Merit Medical Systems Stock
Merit Medical Systems Net Income→
Merit Medical Systems Stock
Merit Medical Systems P/E→
Merit Medical Systems Stock
Merit Medical Systems P/S→
Merit Medical Systems Stock
Merit Medical Systems EBIT→
Merit Medical Systems Stock
Merit Medical Systems Dividend→
Merit Medical Systems Stock
Merit Medical Systems Directors Dealings→
Merit Medical Systems Stock
Merit Medical Systems Stocks→
Merit Medical Systems Stock
Merit Medical Systems Market capitalization→
Merit Medical Systems Stock
Merit Medical Systems Debt→
Merit Medical Systems Stock
Merit Medical Systems Liabilities→
Merit Medical Systems Stock
Merit Medical Systems Equity→
Merit Medical Systems Stock
Merit Medical Systems AAQS→
Merit Medical Systems Stock
Merit Medical Systems Employees→
Merit Medical Systems Stock
Merit Medical Systems ROE→
Merit Medical Systems Stock
Merit Medical Systems ROA→
Merit Medical Systems Stock
Merit Medical Systems ROCE→
Merit Medical Systems Stock
Merit Medical Systems News→
Merit Medical Systems Stock
Merit Medical Systems Analyst Price Targets→

Health Stocks

Mesa LaboratoriesMeridian BioscienceMesoblastMereo BioPharma GroupMetabiomed CoMerdury BiopharmaceuticalMetacare CoMerck Tbk PTMetagenomi TherapeuticsMerck KGaAMetall ZugMerck & CoAll Stocks A–Z →